Clinical study on Anti-acne spot oil in pimples
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2022/07/044013
- Lead Sponsor
- amaskar Ayurved Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
1.Subjects suffering from acne vulgaris [mild and moderate as per Global Acne Grading System (GAGS)] as diagnosed by physician or dermatologist
2.Subjects willing to follow study instructions given by the investigator
1.Subjects with known pre-existing systemic disease necessitating long-term medications.
2.Subjects with known current endocrinal disorders.
3.Subjects taking treatment for menstrual disorders
4.Subjects having systemic treatment for acne vulgaris.
5.Subjects on any other investigational products within 1 month prior to randomization;
6.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure.
7.Pregnant and lactating women
8.Known hypersensitivity to any of the ingredients of Anti-acne Spot Oil
9.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in total number of inflammatory acne lesions on faceTimepoint: Screening / Baseline visit (Day 0), Visit 1 (24 hrs. post skin patch test application), Visit 2 (48 hrs. post skin patch test application) visit 3 (Day 15), visit 4 (Day 30)
- Secondary Outcome Measures
Name Time Method